Interestingly, hydroxychloroquine as a classical SLE treatment improved skin feature and lymphoproliferation in patient with PKCδ deficiency, which revealed that autoreactive B cells could be modulated by hydroxychloroquine.109. This evidence concerns the gene PRKCD and systemic lupus erythematosus.